Private Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Private Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-107,730	Closed	-$5.84M	–	175
2024 Q1	$5.84M	Buy	+107,730	New	+$5.49M	0.83%	30
2019 Q4	–	Sell	-4,095	Closed	-$208K	–	112
2019 Q3	$208K	Sell	4,095 -25,663	-86%	-$1.21M	0.09%	107
2019 Q2	$1.35M	Sell	29,758 -13,599	-31%	-$633K	0.62%	50
2019 Q1	$2.25M	Hold	43,357	–	–	1.27%	32
2018 Q4	$2.25M	Buy	43,357 +1,358	+3%	+$73K	1.27%	32
2018 Q3	$2.47M	Buy	41,999 +726	+2%	+$43.1K	1.26%	23
2018 Q2	$2.28M	Buy	+41,273	New	+$2.23M	1.14%	31

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Advisory Group's BMY Position: Q2 2024 in Review

Private Advisory Group sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 107,730 shares — an estimated $5.84M sold.

Private Advisory Group first reported a position in BMY in Q2 2018 and held it in 7 quarters. The position peaked at $5.84M in Q1 2024. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Private Advisory Group reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Private Advisory Group sold 107,730 Bristol-Myers Squibb shares in Q2 2024, an estimated $5.84M.
Private Advisory Group first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 7 quarters.
Private Advisory Group's Bristol-Myers Squibb position peaked at $5.84M in Q1 2024.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Private Advisory Group's 13F filing for Q2 2024, filed 23 Jul 2024.